Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 28 Sept 2026 for BriaCell Therapeutics Corp..
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Miguel Lopez-Lago: trading record in brief
All filings by Miguel Lopez-Lago on record concern BriaCell Therapeutics Corp. In total, 8 filings cover trades dated from 26 May 2022 to 7 July 2026.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 28 September 2026, reports a share grant in BriaCell Therapeutics Corp. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Miguel Lopez-Lago
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
28,257 sharesPerformance Share UnitsTSXSEDI:4782162
84,775 sharesPerformance Share UnitsTSXSEDI:4782160
94,194 sharesPerformance Share UnitsTSXSEDI:4782159
Performance Share UnitsTSXSEDI:4782155
28,257 sharesCommon SharesTSXSEDI:4748080
84,775 sharesCommon SharesTSXSEDI:4566603
94,194 sharesCommon SharesTSXSEDI:4565262
7 of 7 declarations
